vs

Side-by-side financial comparison of INSMED Inc (INSM) and BOSTON BEER CO INC (SAM). Click either name above to swap in a different company.

BOSTON BEER CO INC is the larger business by last-quarter revenue ($461.6M vs $263.8M, roughly 1.7× INSMED Inc). On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs -4.1%). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs -10.7%).

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

The Boston Beer Company is an American brewery founded in 1984 by James "Jim" Koch and Rhonda Kallman. Boston Beer Company's first brand of beer was named Samuel Adams after Founding Father Samuel Adams, an American revolutionary patriot. Since its founding, Boston Beer has started several other brands, and in 2019 completed a merger with Dogfish Head Brewery.

INSM vs SAM — Head-to-Head

Bigger by revenue
SAM
SAM
1.7× larger
SAM
$461.6M
$263.8M
INSM
Growing faster (revenue YoY)
INSM
INSM
+156.7% gap
INSM
152.6%
-4.1%
SAM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
-10.7%
SAM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INSM
INSM
SAM
SAM
Revenue
$263.8M
$461.6M
Net Profit
$-328.5M
Gross Margin
83.2%
46.4%
Operating Margin
-121.2%
12.4%
Net Margin
-124.5%
Revenue YoY
152.6%
-4.1%
Net Profit YoY
-39.5%
EPS (diluted)
$-1.55
$2.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSM
INSM
SAM
SAM
Q1 26
$461.6M
Q4 25
$263.8M
$385.7M
Q3 25
$142.3M
$537.5M
Q2 25
$107.4M
$587.9M
Q1 25
$92.8M
$453.9M
Q4 24
$104.4M
$402.3M
Q3 24
$93.4M
$605.5M
Q2 24
$90.3M
$579.1M
Net Profit
INSM
INSM
SAM
SAM
Q1 26
Q4 25
$-328.5M
$-22.5M
Q3 25
$-370.0M
$46.2M
Q2 25
$-321.7M
$60.4M
Q1 25
$-256.6M
$24.4M
Q4 24
$-235.5M
$-38.8M
Q3 24
$-220.5M
$33.5M
Q2 24
$-300.6M
$52.3M
Gross Margin
INSM
INSM
SAM
SAM
Q1 26
46.4%
Q4 25
83.2%
43.5%
Q3 25
79.4%
50.8%
Q2 25
73.9%
49.8%
Q1 25
77.1%
48.3%
Q4 24
75.0%
39.9%
Q3 24
77.3%
46.3%
Q2 24
76.8%
46.0%
Operating Margin
INSM
INSM
SAM
SAM
Q1 26
12.4%
Q4 25
-121.2%
-8.6%
Q3 25
-257.1%
11.5%
Q2 25
-291.3%
14.0%
Q1 25
-267.3%
7.4%
Q4 24
-220.6%
-13.9%
Q3 24
-228.4%
7.6%
Q2 24
-319.8%
12.2%
Net Margin
INSM
INSM
SAM
SAM
Q1 26
Q4 25
-124.5%
-5.8%
Q3 25
-260.0%
8.6%
Q2 25
-299.5%
10.3%
Q1 25
-276.4%
5.4%
Q4 24
-225.5%
-9.6%
Q3 24
-236.0%
5.5%
Q2 24
-332.8%
9.0%
EPS (diluted)
INSM
INSM
SAM
SAM
Q1 26
$2.16
Q4 25
$-1.55
$-1.97
Q3 25
$-1.75
$4.25
Q2 25
$-1.70
$5.45
Q1 25
$-1.42
$2.16
Q4 24
$-1.30
$-3.23
Q3 24
$-1.27
$2.86
Q2 24
$-1.94
$4.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSM
INSM
SAM
SAM
Cash + ST InvestmentsLiquidity on hand
$1.4B
$164.1M
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$739.0M
$682.6M
Total Assets
$2.3B
$1.2B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSM
INSM
SAM
SAM
Q1 26
$164.1M
Q4 25
$1.4B
$223.4M
Q3 25
$1.7B
$250.5M
Q2 25
$1.9B
$212.4M
Q1 25
$1.2B
$152.5M
Q4 24
$1.4B
$211.8M
Q3 24
$1.5B
$255.6M
Q2 24
$1.2B
$219.3M
Total Debt
INSM
INSM
SAM
SAM
Q1 26
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Stockholders' Equity
INSM
INSM
SAM
SAM
Q1 26
$682.6M
Q4 25
$739.0M
$846.3M
Q3 25
$945.6M
$911.0M
Q2 25
$1.2B
$912.3M
Q1 25
$99.2M
$897.0M
Q4 24
$285.4M
$916.2M
Q3 24
$483.4M
$1.0B
Q2 24
$38.8M
$1.0B
Total Assets
INSM
INSM
SAM
SAM
Q1 26
$1.2B
Q4 25
$2.3B
$1.2B
Q3 25
$2.4B
$1.2B
Q2 25
$2.5B
$1.3B
Q1 25
$1.8B
$1.2B
Q4 24
$2.0B
$1.3B
Q3 24
$2.1B
$1.4B
Q2 24
$1.8B
$1.4B
Debt / Equity
INSM
INSM
SAM
SAM
Q1 26
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
3.93×
Q3 24
2.01×
Q2 24
30.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSM
INSM
SAM
SAM
Operating Cash FlowLast quarter
$-247.6M
Free Cash FlowOCF − Capex
$-264.2M
FCF MarginFCF / Revenue
-100.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSM
INSM
SAM
SAM
Q1 26
Q4 25
$-247.6M
$39.9M
Q3 25
$-219.8M
$101.8M
Q2 25
$-205.6M
$126.5M
Q1 25
$-262.1M
$1.9M
Q4 24
$-196.0M
$41.9M
Q3 24
$-180.9M
$115.9M
Q2 24
$-123.0M
$96.0M
Free Cash Flow
INSM
INSM
SAM
SAM
Q1 26
Q4 25
$-264.2M
$22.1M
Q3 25
$-222.2M
$89.2M
Q2 25
$-209.1M
$112.2M
Q1 25
$-272.2M
$-8.0M
Q4 24
$-202.8M
$18.4M
Q3 24
$-184.6M
$99.2M
Q2 24
$-129.7M
$75.6M
FCF Margin
INSM
INSM
SAM
SAM
Q1 26
Q4 25
-100.1%
5.7%
Q3 25
-156.1%
16.6%
Q2 25
-194.6%
19.1%
Q1 25
-293.2%
-1.8%
Q4 24
-194.1%
4.6%
Q3 24
-197.6%
16.4%
Q2 24
-143.6%
13.1%
Capex Intensity
INSM
INSM
SAM
SAM
Q1 26
Q4 25
6.3%
4.6%
Q3 25
1.7%
2.3%
Q2 25
3.2%
2.4%
Q1 25
10.8%
2.2%
Q4 24
6.5%
5.8%
Q3 24
3.9%
2.8%
Q2 24
7.5%
3.5%
Cash Conversion
INSM
INSM
SAM
SAM
Q1 26
Q4 25
Q3 25
2.21×
Q2 25
2.09×
Q1 25
0.08×
Q4 24
Q3 24
3.46×
Q2 24
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons